InvestorsHub Logo
Followers 6
Posts 601
Boards Moderated 0
Alias Born 09/05/2013

Re: Dennisb68 post# 1000

Friday, 02/01/2019 10:23:18 PM

Friday, February 01, 2019 10:23:18 PM

Post# of 3504
Hard to decipher but my take is, it was 'designated' as an orphan drug today, but not approved for the indication requested...that being treatment of glioblastoma. It obviously has to go through phase i ii iii trials before approval. The orphan drug designation should be a shorter quicker path to approval...a confirmation of evidence showing its potential!

Hopefully interpreting that correctly...cant wait for official press release to see how high we go!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MBRX News